Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Post-exposure vaccination against hepatitis A].

Dominique Gendrel1, Odile Launay

  • 1Groupe Hospitalier Cochin-Saint Vincent de Paul, Paris, France. dominique.gendrel@svp.ap-hop-paris.fr

Therapie
|September 1, 2005
PubMed
Summary

Routine hepatitis A vaccination is unnecessary in France due to decreased incidence. However, post-exposure prophylaxis for exposed individuals is crucial, with vaccination being a viable option within days of exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of care-pathways of older adults hospitalized for influenza-like illness before institutionalization: a French SNDS-based study.

BMC health services research·2026
Same author

Risk factors for acquisition of SARS-CoV-2 Omicron variant among a prospective cohort of French Healthcare Workers: impact of hybrid immunity.

Scientific reports·2026
Same author

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Scientific reports·2026
Same author

Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study.

Vaccine·2026
Same author

RSV vaccination in immunocompromised adults.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Vaccinology

Context:

  • Decreased incidence of Hepatitis A in France.
  • Limited availability of non-specific immunoglobulins for post-exposure prophylaxis.
  • Established protocols for post-exposure prophylaxis in other countries, such as the UK.

Purpose:

  • To evaluate the necessity of routine Hepatitis A vaccination in France.
  • To address the challenge of post-exposure prophylaxis for Hepatitis A.
  • To highlight the potential of vaccination as a post-exposure prophylaxis method.

Summary:

  • Hepatitis A incidence has significantly declined in France, making routine vaccination unnecessary.
  • Post-exposure prophylaxis for Hepatitis A is a concern, as recommended immunoglobulins are unavailable.
  • Vaccination within 7 days of exposure is effective for household contacts and in communities like nursery schools, as recommended by the British Advisory Board.

Impact:

  • Clinicians should inform families about the availability and benefits of post-exposure vaccination.
  • This approach offers an alternative prophylactic measure in the absence of immunoglobulin availability.
  • Facilitates informed decision-making for families regarding Hepatitis A prevention after exposure.

Related Experiment Videos